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AbsTrACT
background/Aims Proliferative diabetic retinopathy 
(PDR) is a severe blinding condition. We investigated 
whether retinal metabolism, measured by retinal 
oximetry, may predict PDR activity after panretinal laser 
photocoagulation (PRP).
Methods We performed a prospective, interventional, 
clinical study of patients with treatment-naive PDR. 
Wide-field fluorescein angiography (OPTOS, Optomap) 
and global and focal retinal oximetry (Oxymap T1) were 
performed at baseline (BL), and 3 months (3M) after 
PRP. Angiographic findings were used to divide patients 
according to progression or non-progression of PDR after 
PRP. We evaluated differences in global and focal retinal 
oxygen saturation between patients with and without 
progression of PDR after PRP treatment.
results We included 45 eyes of 37 patients (median 
age and duration of diabetes were 51.6 and 20 years). 
Eyes with progression of PDR developed a higher 
retinal venous oxygen saturation than eyes with non-
progression at 3M (global: +5.9% (95% CI –1.5 to 
12.9), focal: +5.4%, (95% CI –4.1 to 14.8)). Likewise, 
progression of PDR was associated with a lower 
arteriovenular (AV) oxygen difference between BL and 
3M (global: –6.1%, (95% CI –13.4 to –1.4), focal: 
–4.5% (95% CI –12.1 to 3.2)). In a multiple logistic 
regression model, increment in global retinal venular 
oxygen saturation (OR 1.30 per 1%-point increment, 
p=0.017) and decrement in AV oxygen saturation 
difference (OR 0.72 per 1%-point increment, p=0.016) 
at 3M independently predicted progression of PDR.
Conclusion Development of higher retinal venular 
and lower AV global oxygen saturation independently 
predicts progression of PDR despite standard PRP and 
might be a potential non-invasive marker of angiogenic 
disease activity.
InTroduCTIon
Diabetic retinopathy (DR) is a leading cause of 
blindness in the working-age population glob-
ally.1–3 Proliferative diabetic retinopathy (PDR) is 
an ischaemic end-stage complication characterised 
by new retinal vessels (proliferations) that often 
lead to vitreous haemorrhage and/or tractional 
retinal detachment. The Diabetic Retinopathy 
Study demonstrated that panretinal laser photo-
coagulation (PRP) reduces the risk of severe visual 
loss by 57% in patients with high-risk PDR.4 The 
purported mechanism of PRP has been debated 
for decades, but a general hypothesis is that energy 
delivered by the laser is absorbed by the retinal 
pigment epithelium and transformed to heat energy 
conducted to the neurosensory part of the retina, 
leading to thermic destruction of the affected retinal 
areas, which reduces the hypoxic load.4–6 While 
PRP is now considered standard of care for PDR, 
PRP is a global retinal treatment with little intra-in-
dividual variation. The inability to accurately 
predict progression of disease after PRP is partly 
because all patients are given the same amount of 
laser treatment. Some patients may have insuffi-
cient treatment while excessive treatment has been 
given to others. Hence, some might have disease 
progression with recurrent vitreous haemorrhage, 
and others may develop side effects like visual field 
loss, night blindness or diabetic macular oedema.5–7
The level of retinal metabolism may be an indi-
cator of disease activity after PRP. This can be 
non-invasively measured by retinal oxygen satura-
tion using a spectrophotometric retinal oximeter,8 
and increasing levels of DR has been associated 
with increased retinal venular oxygen satura-
tion.9–12 Hence, retinal oxygen saturation could act 
as an early indicator of PRP treatment response, 
and thereby be a valuable tool in the individualised 
patient management. In order to test if optimal 
levels of PRP can be assessed preoperatively, the 
main aim of this study was to investigate if retinal 
oximetry prior to PRP could be used as a non-inva-
sive marker of postoperative PDR activity.
MATerIAls And MeThods
We carried out a 3-month prospective, interven-
tional study of 45 treatment-naive eyes with PDR 
referred to Odense University Hospital, Denmark 
between 1 August 2014 and 31 October 2015. 
We excluded patients with clinical significant 
macular oedema, previous PRP in the study eye, 
treatment-demanding cataract, age <18 years or 
pregnancy.
At baseline (BL), all patients provided a full 
medical history (including type of diabetes) and 
underwent a standard ophthalmic examination 
including slit lamp examination performed in 
mydriasis with tropicamide 10 mg/mL (Mydriacyl) 
and Phenylephedrine 10% (Metaoxedrin), optical 
coherence tomography (OCT) by 3D OCT-2000 
Spectral domain OCT (Topcon, Tokyo, Japan), 
and widefield fluorescein angiography (Optomap; 
Optos, Dunfermline, Scotland, UK). All examina-
tions were done by trained personnel.
BL examinations included blood pressure (BP) 
on the upper arm using BP measuring equipment 
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(Omron 705CP, Hoofdrop, The Netherlands), haemoglobin A1c 
(HbA1c) and retinal oximetry (Oxymap model T1, Oxymap, 
software V.2.4.2, Reykjavik, Iceland).
Patients then received PRP in two sessions, 1 week apart 
by a navigated laser system (Navilas, OD-OS GmbH, Berlin, 
Germany). The patients were given a local anaesthetic (oxybu-
procaine hydrochloride 0.4%), and a Navilas 34 mm or 38 mm 
contact lens was used. All treatments were given by certified 
personnel (TLT and JG), and treatment specifications were auto-
matically provided by the laser system after each session.
Follow-up was performed 3 months (3M) after PRP. Progres-
sion of PDR were defined as formation of new retinal prolifera-
tions, increased area of one or more proliferations or increased 
area of fluorescein leakage on angiography, as defined by clinical 
guidelines. Eyes with progression received supplementary PRP 
as needed, after follow-up examinations had been performed.
retinal oxygen saturation
Oxymap T1 was used to assess the retinal oxygen saturation 
(figure 1). The equipment and technique are described else-
where.13 All gradings were masked according to the PDR activity 
at follow-up and done by a single trained grader (TLT) in accor-
dance with a prespecified grading protocol. Optic disc centred 
images were used for grading. Two rings were semi-automati-
cally placed around the optic disc. The inner ring was manu-
ally placed between 20 and 30 pixels from the edge of the optic 
disc to avoid erroneous measurements due to reflection from 
the optic disc and the surrounding nerve fibre layer. The outer 
ring was automatically placed at three times the diameter of the 
inner ring. The oximetry measurements were done between the 
inner and outer ring. One larger arteriole and venule in each 
quadrant were automatically traced at a length of 50–200 pixels. 
If the length of the vessel was less than 50 pixels proximal to 
the first branching point, the first branch vessel was chosen for 
tracing. Measurements at follow-up were done on the same 
vessel segment. Two methods were used: Global measurements 
were defined as the mean retinal arteriolar and venular oxygen 
saturation of all four quadrants, and focal measurements were 
calculated as the retinal arteriolar and venular oxygen saturation 
of the affected retinal quadrant in patients with only one neovas-
cularisation elsewhere. In addition to the arteriolar and venular 
measurements, the arteriovenular (AV) difference was included 
in the analysis.
Approvals
The study was approved by the Regional Scientific Ethics 
Committee (ID S-20140046), The Danish Data Protection 
Agency (ID 14/16546), registered at Clinical Trials on the fourth 
of June 2014 (ID NCT02157350), and performed in accordance 
with the criteria of the Helsinki II Declaration and good clinical 
practice. All patients gave informed consent before inclusion in 
the study. Furthermore, we attest that we have obtained appro-
priate permissions and paid any required fees for use of copy-
right-protected materials.
statistical analyses
All statistical calculations were performed using STATA V.14.1 
(StataCorp), and p values under 0.05 were considered statis-
tically significant. At BL, categorical data are presented as 
percentage and continuous data as median with interquartile 
range (9IQR. Differences between patients with progression and 
non-progression of PDR were compared by the Mann-Whitney 
U test for continuous data and χ2 for categorical data. Multiple 
logistic regression was performed with retinal oximetry measure-
ments as predictors for progression of PDR (with adjustments 
for sex, age, duration of diabetes, HbA1c, systolic and diastolic 
BP and retinal laser energy). A standard power calculation on 
the arteriolar and venular oxygen saturation stated the inclusion 
of minimum 27 patients in the study (arteriolar: α 5%, β 20%, 
mean 92.2, difference 2, spread 3.7, n=27, venular: α 5%, β 
20%, mean 55.6, difference 3.5, spread 6.3, n=26).
resulTs
A total of 45 eyes (37 patients) were examined. Nineteen patients 
had type 1 and 18 had type two diabetes. At BL, there was no 
significant difference in the retinal oxygen saturation between 
patients with type 1 and type two diabetes (arteriolar 96.1% vs 
97.0%, p=0.79 venular 64.4% vs 67.9%, p=0.17), and there-
fore the data was merged.
The age and duration of diabetes (median and IQR) was 
51.6±15 and 20±11 years, and 64% were male. HbA1c was 
7.9%±1.5% (63±16 mmol/mol), and the median and IQR 
BP was 153±37/83.5±21 mm Hg. Retinal arteriolar and venular 
oxygen saturation was 96.3%±7.2% and 67.2%±13.6%, 
respectively.
At baseline in global as well as focal analysis, patients with 
and without progression of PDR did not differ according to age, 
duration of diabetes, HbA1c, BP, total laser energy delivered, 
retinal oximetry image quality or retinal oxygen saturation (arte-
riolar, venular and arteriovenular difference) (table 1).
Between BL and 3M, three eyes were excluded due to vitrec-
tomy (n=2) or death (n=1), leaving a total of 42 eyes for global 
measurements and 24 for focal measurements. At 3M for global 
measurements, 12 eyes had progression of PDR as opposed to 30 
eyes that did not progress. Correspondingly, in focal measure-
ments, progression and non-progression of PDR was found for 
seven and 17 eyes, respectively.
retinal arteriolar oxygen saturation
In global as well as focal measurements, there was no difference 
in retinal arteriolar oxygen saturation between the two groups, 
neither at BL, 3M or in the differences between BL and 3M 
(figure 2, figure 3, figure 4, figure 5 and table 2).
Figure 1 Retinal oxygen saturation. Oxymap T1 image showing traced 
vessels with overlaying colour map indicating oxygen saturation by 
colour on right eye. The oxygen saturation is measured in traced vessels, 
seen as white lines on either side of the vessels, between the blue rings. 
Retinal vessels covered in white areas are excluded vessel segments.
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retinal venular oxygen saturation
There was a decrease in global retinal venular oxygen satura-
tion between BL and 3M in patients without progression of PDR 
(67.2% vs 63.8%, p=0.04) (figure 2). Likewise, at 3M, patients 
with progression of PDR had developed a higher difference in 
retinal venular oxygen saturation than patients without progres-
sion of PDR (+4.1% vs −1.8%, p=0.02) (figure 4). In a multiple 
logistic regression model, an increase in global retinal venular 
oxygen saturation between BL and 3M was independently asso-
ciated with progression of PDR (OR 1.30 per 1%-point incre-
ment, 95% CI 1.05 to 1.62, p=0.02) (table 2).
In the focal retinal venular oxygen measurements, there were 
no differences between BL and 3M between groups (figure 3), 
but at 3M, patients with progression of PDR had a higher incre-
ment from BL than patients without progression (+3.9% vs 
−1.5%, p=0.04) (figure 5).
retinal AV oxygen difference
In the global measurements, the retinal oxygen saturation 
AV difference between patients with progression and non-pro-
gression of PDR differed at 3M (progression −4.1% vs non-pro-
gression +2.0, p<0.01) (figure 4). This was confirmed in the 
multiple logistic regression analysis (OR for progression of PDR 
0.72 per 1.0%-point increment in AV difference, 95% CI 0.55 to 
0.94, p=0.02) (table 2).
Table 1 Baseline characteristics according to activity of proliferative diabetic retinopathy at follow-up month 3
baseline 
characteristics
Global (median±IQr) Focal (median±IQr)
Pdr progression Pdr non-progression p value Pdr progression Pdr non-progression p value
Eyes, n 12 30 7 17
Sex (men/women), n 6/6 22/8 0.15 3/4 14/3 0.05
Age, years 51.3±18.0 53.8±26.0 0.47 51.1±31.7 42.3±21.8 0.97
Diabetes duration, years 15.5±22.5 20±12.0 0.28 12±8.0 20±12.0 0.07
HbA1c, % 8.2±2.4 7.9±1.5 0.96 8.4±2.8 7.8±1.2 0.43
HbA1c, mmol/mol 66.5±26.5 63±16.0 0.96 68±31.0 62±13.0 0.43
Systolic blood pressure, 
mm Hg
159.5±29.5 153±39.0 0.99 146±37.0 140±29.0 0.97
Diastolic blood pressure, 
mm Hg
77.5±28.0 83.5±12.0 0.44 83±28.0 82±14.0 0.82
Amount of laser energy, 
Joule
13.8±5.0 13.2±4.6 0.56 13.6±6.7 11.5±4.1 0.68
Oximetry image quality, 
0–10
8.4±1.2 8.0±1.0 0.51 8.3±1.2 8.1±0.9 0.85
Arteriolar oxygen 
saturation, %
96.1±7.8 95.3±7.8 0.43 93.6±8.1 97.6±9.0 0.32
Venular oxygen 
saturation, %
65.2±16.3 67.2±13.4 0.96 62.0±18.6 68.2±14.2 0.59
Arteriovenular oxygen 
difference saturation, %
31.9±14.1 30.2±11.1 0.58 28.5±24.0 34.6±20.6 0.36
Baseline characteristics in global and focal measurements according to activity of proliferative diabetic retinopathy (PDR) 3 months after panretinal laser photocoagulation. 
Continuous data are presented as median with IQR. Differences between groups were compared with the Mann-Whitney U test for continuous data and χ2 test for categorical. 
Oximetry image quality ranged from 0=poor to 10=excellent.
IQR, interquartile range; PDR, proliferative diabetic retinopathy.
Figure 2 Global retinal oxygen saturation in eyes with progression 
or non-progression of proliferative diabetic retinopathy (PDR) before 
and after panretinal laser photocoagulation. All values are given as 
median with inter quartile range (IQR). AV, arteriovenular. *Statistically 
significant. 
Figure 3 Focal retinal oxygen saturation in eyes with progression or 
non-progression of proliferative diabetic retinopathy (PDR) 
before and after panretinal laser photocoagulation. All values are 
given as median with interquartile range (IQR). AV, arteriovenular. 
*Statistically significant. 
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In the focal analysis, a decrease in AV difference was seen 
between BL and 3M in patients with progression of PDR 
(28.5% vs 24.0%, p=0.03) (figure 3). There was also a different 
AV difference between patients with and without progression of 
PDR from BL to 3M (−3.1% vs +1.4, p<0.04) (figure 5).
dIsCussIon
In this prospective study of patients with treatment-naive PDR, 
prelaser retinal oxygen saturation was not able to predict post-
operative disease activity. However, the study also demonstrates 
postoperative changes in the retinal oxygen metabolism that 
were closely linked to disease activity 3 months after PRP. In fact, 
each 1% increase in retinal venular oxygen saturation was inde-
pendently associated with a 30% higher risk of increased PDR 
activity despite laser treatment.
It has consistently been demonstrated that patients with DR 
have higher retinal venular oxygen saturation as compared 
with healthy controls.9 11 12 14 Likewise, the retinal arteriolar 
and venular oxygen saturation increases with increasing levels 
of DR.10 11 The paradoxical difference between the high intra-
vascular oxygen saturation and the ischaemic retinal tissue has 
been hypothesised to be caused by oxygen entrapment due to 
capillary closure, blood shunting around non-perfused retinal 
areas, thickening of the capillary vessel walls, and greater 
affinity of haemoglobin for oxygen in patients with diabetes.11 
An earlier study by Hammer et al demonstrated a trend towards 
lower retinal venular oxygen saturation in patients with PDR 
previously treated with PRP as compared with treatment-naive 
patients.12 In the present study, we demonstrated that this finding 
was only present in patients who were stabilised after PRP. This 
identifies retinal oxygen saturation as a non-invasive marker of 
disease activity, and might be of assistance to clinicians in the 
postoperative phase.
The retinal AV oxygen difference is considered as a pseudo-in-
dicator of retinal oxygen consumption.11 In the present study, 
each 1%-point increase in the retinal AV oxygen difference 
between BL and 3M independently reduced the risk of progres-
sion of PDR by 28%, thereby indicating higher retinal oxygen 
use for those patients with a favourable treatment response. One 
explanation to the differences in retinal venular and AV oxygen 
saturation seen may be found in the hypoxic areas of the 
retina. These areas represent oxygen deficit tissue that react by 
increasing their retinal oxygen demand. This increase in oxygen 
demand causes the retinal oxygen saturation to increase, which 
unfortunately does not aid the hypoxic areas due to the overall 
poor condition of the capillaries. When successful PRP treatment 
is obtained, the hypoxic tissue is adequately decreased in area, 
thereby decreasing the retinal oxygen demand and lowering the 
venous and AV oxygen saturation.
We did not find the same differences in the arteriolar oxygen 
saturation. Earlier studies have shown a large difference in 
reported retinal arteriolar oxygen saturation as compared with 
the venules,11 12 15 and this was the case despite a general higher 
retinal arteriolar oxygen saturation in patients with PDR.9 10 16 
This variation in reported retinal arteriolar oxygen saturation 
could be due to variance in laser treatment or oxygen saturation 
measurement protocols or equipment. Likewise, there could be 
a ceiling effect for arteriolar values that would not be present for 
venular measurements.
DR has traditionally been considered a global retinal isch-
aemic disease. However, some patients only have local lesions 
and may represent more focal phenotypes. In the present study, 
24 patients only had a single proliferation elsewhere. For these 
patients, we were able to replicate the global oximetry find-
ings with higher retinal venular oxygen saturation and lower 
AV differences at follow-up for patients with progression of 
PDR. Even though these findings are limited by a low number 
of patients in this subgroup, the focal findings should raise the 
question of a possible retained ischaemic overdrive in the retinal 
quadrant with the proliferation. Previous studies on healthy 
individuals have found regional differences in the retinal oxygen 
saturation, although the same difference has not been shown in 
patients with PDR.17 18 These regional differences could explain 
why we did not find a difference in the oxygen saturation 
between the quadrant containing a proliferation and the oxygen 
saturation of the three adjacent quadrants (data not shown). 
Upcoming studies should address the possibility of a more focal 
treatment for patients with focal ischaemia.
Limitations of the study need to be considered. This includes 
a limited number of patients, which could affect the outcome 
of the study, although the power calculation was respected. An 
untreated observation group would have strengthened the study, 
but this was not possible due to ethical reasons. Furthermore, a 
trend towards a skewed distribution of women was seen in the 
focal measurements at 3M. This may have confounded the inter-
pretation of the focal results. Finally, retinal blood flow analyses 
were not included in the study.
Figure 4 Difference in global retinal oxygen saturation from 
baseline to follow-up in eyes with proliferative diabetic retinopathy 
(PDR) according to disease activity at follow-up. All values are given 
as median. AV, arteriovenular. *Statistically significant. 
Figure 5 Difference in focal retinal oxygen saturation from baseline 
to follow-up in eyes with proliferative diabetic retinopathy (PDR) 
according to disease activity at follow-up. All values are given as 
median. AV, arteriovenular. *Statistically significant. 
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In conclusion, the present study demonstrates that in patients 
with treatment-naive PDR, the retinal oxygen saturation cannot 
be used as a preoperative indicator of treatment outcome, but 
that the postoperative retinal oxygen metabolism closely reflects 
the disease activity and, hence, may be used to assess the need 
of adjunctive laser therapy. Upcoming studies should address if 
less invasive treatment of patients with focal PDR have the same 
efficacy but fewer side effects than standard-of-care PRP.
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Focal (n=24)
  Arteriolar 1.0% 0.86 (0.65 to 1.14) 0.285 0.98 (0.83 to 1.15) 0.768 1.30 (0.81 to 2.01) 0.274
  Venular 1.0% 0.90 (0.75 to 1.09) 0.290 1.00 (0.86 to 1.16) 0.980 1.33 (0.88 to 1.99) 0.173
  Arteriovenular 1.0% 1.02 (0.88 to 1.19) 0.756 0.99 (0.86 to 1.13) 0.835 0.89 (0.68 to 1.15) 0.360
Multiple logistic regression model (adjusted for age, sex, duration of diabetes, HbA1c, and amount of laser energy) indicating risk of progression of proliferative diabetic 
retinopathy 3 months after panretinal laser photocoagulation according to level of retinal oxygen saturation at baseline, follow-up and between baseline and follow-up. Risk 
indicated as odds ratio (OR) with 95% confidence interval (CI). *Statistically significant.
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